Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SA001 in Dry Eye Syndrome
NCT03723798Phase 2Completed
- Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Start
- Nov 2017
- Primary completion
- Oct 2018
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rebamipide mofetil in dry eye syndrome (DED), sponsored by Samjin Pharmaceutical Co., Ltd.. Started Nov 2017; status: completed.
02
Drugs
rebamipide mofetil
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03723798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03723798.